BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 20385935)

  • 1. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Brockhurst RJ; Hayes KC; Johnson EJ; Anderson EJ; Johnson CA; Gaudio AR; Willett WC; Schaefer EJ
    Arch Ophthalmol; 2010 Apr; 128(4):403-11. PubMed ID: 20385935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
    Arch Ophthalmol; 2004 Sep; 122(9):1297-305. PubMed ID: 15364708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
    Arch Ophthalmol; 2004 Sep; 122(9):1306-14. PubMed ID: 15364709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter from the DSMC regarding a clinical trial of lutein in patients with retinitis pigmentosa.
    Wittes J; Gorin MB; Mayne ST; McCarthy CS; Sternberg P; Wall M
    Arch Ophthalmol; 2011 May; 129(5):675; author reply 675-6. PubMed ID: 21555632
    [No Abstract]   [Full Text] [Related]  

  • 5. How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa?
    Massof RW; Fishman GA
    Arch Ophthalmol; 2010 Apr; 128(4):493-5. PubMed ID: 20385948
    [No Abstract]   [Full Text] [Related]  

  • 6. ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Willett WC
    Arch Ophthalmol; 2012 Jun; 130(6):707-11. PubMed ID: 22332205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
    Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFranco C; Willett W
    Arch Ophthalmol; 1993 Jun; 111(6):761-72. PubMed ID: 8512476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].
    Bahrami H; Melia M; Dagnelie G
    BMC Ophthalmol; 2006 Jun; 6():23. PubMed ID: 16759390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
    Birch DG; Bernstein PS; Iannacone A; Pennesi ME; Lam BL; Heckenlively J; Csaky K; Hartnett ME; Winthrop KL; Jayasundera T; Hughbanks-Wheaton DK; Warner J; Yang P; Fish GE; Teske MP; Sklaver NL; Erker L; Chegarnov E; Smith T; Wahle A; VanVeldhuisen PC; McCormack J; Lindblad R; Bramer S; Rose S; Zilliox P; Francis PJ; Weleber RG
    JAMA Ophthalmol; 2018 Aug; 136(8):849-856. PubMed ID: 29879277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa.
    Berson EL; Weigel-DiFranco C; Rosner B; Gaudio AR; Sandberg MA
    JAMA Ophthalmol; 2018 May; 136(5):490-495. PubMed ID: 29596553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa.
    Vingolo EM; Rocco M; Grenga P; Salvatore S; Pelaia P
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):93-8. PubMed ID: 17674017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
    Nakazawa M; Ohguro H; Takeuchi K; Miyagawa Y; Ito T; Metoki T
    Ophthalmologica; 2011; 225(2):120-6. PubMed ID: 20948238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between visual disability and visual scores in patients with retinitis pigmentosa.
    Sumi I; Matsumoto S; Okajima O; Shirato S
    Jpn J Ophthalmol; 2000; 44(1):82-7. PubMed ID: 10698030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease course of patients with pericentral retinitis pigmentosa.
    Sandberg MA; Gaudio AR; Berson EL
    Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome.
    Aleman TS; Duncan JL; Bieber ML; de Castro E; Marks DA; Gardner LM; Steinberg JD; Cideciyan AV; Maguire MG; Jacobson SG
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1873-81. PubMed ID: 11431456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of macular pigment optical density to serum lutein in retinitis pigmentosa.
    Sandberg MA; Johnson EJ; Berson EL
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1086-91. PubMed ID: 19797209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of decline in regions of the visual field defined by frequency-domain optical coherence tomography in patients with RPGR-mediated X-linked retinitis pigmentosa.
    Birch DG; Locke KG; Felius J; Klein M; Wheaton DK; Hoffman DR; Hood DC
    Ophthalmology; 2015 Apr; 122(4):833-9. PubMed ID: 25556114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial.
    Rotenstreich Y; Belkin M; Sadetzki S; Chetrit A; Ferman-Attar G; Sher I; Harari A; Shaish A; Harats D
    JAMA Ophthalmol; 2013 Aug; 131(8):985-92. PubMed ID: 23700011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.